Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease

PloS One
Mathieu MarellaTakao Yagi

Abstract

It is widely recognized that mitochondrial dysfunction, most notably defects in the NADH-quinone oxidoreductase (complex I), is closely related to the etiology of sporadic Parkinson's disease (PD). In fact, rotenone, a complex I inhibitor, has been used for establishing PD models both in vitro and in vivo. A rat model with chronic rotenone exposure seems to reproduce pathophysiological conditions of PD more closely than acute mouse models as manifested by neuronal cell death in the substantia nigra and Lewy body-like cytosolic aggregations. Using the rotenone rat model, we investigated the protective effects of alternative NADH dehydrogenase (Ndi1) which we previously demonstrated to act as a replacement for complex I both in vitro and in vivo. A single, unilateral injection of recombinant adeno-associated virus carrying the NDI1 gene into the vicinity of the substantia nigra resulted in expression of the Ndi1 protein in the entire substantia nigra of that side. It was clear that the introduction of the Ndi1 protein in the substantia nigra rendered resistance to the deleterious effects caused by rotenone exposure as assessed by the levels of tyrosine hydroxylase and dopamine. The presence of the Ndi1 protein also prevented cell...Continue Reading

References

Dec 12, 1991·European Journal of Pharmacology·M GerlachM B Youdim
Sep 28, 1990·Science·R Langer
Apr 1, 1989·Current Opinion in Cell Biology·J K Chipman
Jan 1, 1980·Neuroscience·C J Pycock
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·J AraH Ischiropoulos
Apr 29, 1999·Journal of Neuroscience Research·A H StokesK E Vrana
Mar 22, 2000·Chemical Research in Toxicology·J L BoltonT J Monks
Dec 2, 2000·Nature Neuroscience·R BetarbetJ T Greenamyre
Sep 17, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Byoung Boo SeoAkemi Matsuno-Yagi
Oct 19, 2002·Behavioural Brain Research·M Alam, W J Schmidt
Jun 5, 2003·American Journal of Epidemiology·Stephen K Van Den EedenLorene M Nelson
Aug 14, 2003·Parkinsonism & Related Disorders·J Timothy GreenamyreTodd B Sherer
Dec 14, 2004·Microbiology and Molecular Biology Reviews : MMBR·Ana M P MeloMiguel Teixeira
Jul 8, 2005·Human Gene Therapy·Corinna BurgerRonald J Mandel
Jul 19, 2005·Annual Review of Neuroscience·Darren J MooreTed M Dawson
Feb 14, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Todd B ShererJ William Langston
May 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lothar Kussmaul, Judy Hirst
Jul 11, 2006·The Journal of Clinical Investigation·Joseph M SavittTed M Dawson
Oct 14, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jason R RichardsonGary W Miller
Jun 22, 2007·The Journal of Biological Chemistry·Mathieu MarellaTakao Yagi
Jul 20, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Myriam Escobar-KhondikerGünter U Höglinger

❮ Previous
Next ❯

Citations

Jan 31, 2012·Experimental Neurology·Robert E Burke, Karen O'Malley
Jan 19, 2010·Annual Review of Pathology·Douglas C WallaceVincent Procaccio
Nov 12, 2009·Journal of Bioenergetics and Biomembranes·Mathieu MarellaAkemi Matsuno-Yagi
May 4, 2010·Eukaryotic Cell·Ana CastroArnaldo Videira
May 4, 2010·Proceedings of the National Academy of Sciences of the United States of America·Alberto SanzHoward T Jacobs
Oct 13, 2011·PloS One·Mathieu MarellaTakao Yagi
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Celine Perier, Miquel Vila
Sep 26, 2012·The Journal of Biological Chemistry·Giuseppe CanninoEric Dufour
Jun 24, 2010·Journal of Inherited Metabolic Disease·Hélène Cwerman-ThibaultMarisol Corral-Debrinski
Dec 29, 2010·Parkinson's Disease·Jennifer Barber-SinghTakao Yagi
Feb 15, 2011·Parkinson's Disease·A R EstevesS M Cardoso
Jun 13, 2013·Trends in Genetics : TIG·G Jane FarrarSophia Millington-Ward
Feb 9, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Ariana P GattJoseph M Bateman
Jan 28, 2016·Aging and Disease·Xiaoting LuoLiang-Jun Yan
Jun 26, 2012·Toxicology·Adrian LupescuFlorian Lang
Nov 17, 2009·Journal of the Neurological Sciences·Rongqin HuangYuanying Pei
May 26, 2009·Experimental Neurology·Janet M Dubinsky
Aug 6, 2008·Journal of Neurochemistry·Miquel VilaCeline Perier
Feb 5, 2009·Journal of Internal Medicine·S Koene, J Smeitink
Jan 2, 2014·Brain and Behavior·Craig F FerrisTakao Yagi
May 21, 2011·Journal of Neuroscience Research·Syama Sundar BoyallaSusanne Arnold
Jun 15, 2010·Environmental and Molecular Mutagenesis·Inna N ShokolenkoGlenn L Wilson
Sep 8, 2010·Developmental Disabilities Research Reviews·Tina WenzCarlos T Moraes
Aug 16, 2014·Biochimica Et Biophysica Acta·Dmytro V GospodaryovHoward T Jacobs
Jun 16, 2015·The Journal of Clinical Investigation·Alevtina D ZharikovEdward A Burton
Dec 19, 2012·Neurochemistry International·Brian M Polster
Jul 3, 2013·Neurobiology of Disease·Mathieu MarellaTakao Yagi
Apr 27, 2010·Biochimica Et Biophysica Acta·Magdalena MisiakSusanne Arnold
Sep 19, 2009·Biochimica Et Biophysica Acta·Helen A L TuppenRobert W Taylor
Sep 17, 2014·Journal of Inherited Metabolic Disease·Immo E Scheffler
Jan 19, 2013·Free Radical Biology & Medicine·Laurie H Sanders, J Timothy Greenamyre
Apr 26, 2016·Biochemistry·Johannes SalewskiPeter Hildebrandt

❮ Previous
Next ❯

Methods Mentioned

BETA
Confocal microscopy

Software Mentioned

OsiriX
ImageJ
Cinelerra

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Byoung Boo SeoAkemi Matsuno-Yagi
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Todd B ShererJ Timothy Greenamyre
© 2021 Meta ULC. All rights reserved